Literature DB >> 20030434

Zonisamide in Parkinson's disease: profile report.

Lily P H Yang1, Caroline M Perry.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20030434     DOI: 10.2165/11203950-000000000-00000

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


× No keyword cloud information.
  13 in total

1.  Biomedicine. Parkinson's--divergent causes, convergent mechanisms.

Authors:  J Timothy Greenamyre; Teresa G Hastings
Journal:  Science       Date:  2004-05-21       Impact factor: 47.728

Review 2.  Parkinson's disease.

Authors:  Ali Samii; John G Nutt; Bruce R Ransom
Journal:  Lancet       Date:  2004-05-29       Impact factor: 79.321

3.  Zonisamide improves motor function in Parkinson disease: a randomized, double-blind study.

Authors:  Miho Murata; Kazuko Hasegawa; Ichiro Kanazawa
Journal:  Neurology       Date:  2007-01-02       Impact factor: 9.910

4.  Zonisamide has beneficial effects on Parkinson's disease patients.

Authors:  M Murata; E Horiuchi; I Kanazawa
Journal:  Neurosci Res       Date:  2001-12       Impact factor: 3.304

5.  Effects of zonisamide on dopaminergic system.

Authors:  M Okada; S Kaneko; T Hirano; K Mizuno; T Kondo; K Otani; Y Fukushima
Journal:  Epilepsy Res       Date:  1995-11       Impact factor: 3.045

6.  Zonisamide: in Parkinson's disease.

Authors:  Lily P H Yang; Caroline M Perry
Journal:  CNS Drugs       Date:  2009-08       Impact factor: 5.749

Review 7.  Clinical pharmacology and mechanism of action of zonisamide.

Authors:  Victor Biton
Journal:  Clin Neuropharmacol       Date:  2007 Jul-Aug       Impact factor: 1.592

8.  Effects of zonisamide on extracellular levels of monoamine and its metabolite, and on Ca2+ dependent dopamine release.

Authors:  M Okada; S Kaneko; T Hirano; M Ishida; T Kondo; K Otani; Y Fukushima
Journal:  Epilepsy Res       Date:  1992-11       Impact factor: 3.045

9.  Changes in prevalence and incidence of Parkinson's disease in Japan during a quarter of a century.

Authors:  Mika Yamawaki; Masayoshi Kusumi; Hisanori Kowa; Kenji Nakashima
Journal:  Neuroepidemiology       Date:  2009-02-11       Impact factor: 3.282

Review 10.  Pharmacotherapy for Parkinson's disease.

Authors:  Jack J Chen; David M Swope
Journal:  Pharmacotherapy       Date:  2007-12       Impact factor: 4.705

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.